Multiple endocrine neoplasia type 2B--genetic basis and clinical expression (Q34253160)

31 July 2017

1 reference

title

Multiple endocrine neoplasia type 2B--genetic basis and clinical expression (English)

1 reference

multiple endocrine neoplasia

31 July 2017

1 reference

Lee NC

1

1 reference

PubMed ID

11356339

31 July 2017

Norton JA

series ordinal

2

1 reference

31 July 2017

1 November 2000

1 reference

31 July 2017

1 reference

31 July 2017

9

1 reference

31 July 2017

3

1 reference

31 July 2017

111-118

1 reference

Genetic aspects of adenomatosis of endocrine glands

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

The association of pheochromocytoma with carcinoma of the thyroid gland

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Multiple mucosal neuromata with endocrine tumours: a syndrome allied to von Recklinghausen's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Multiple mucosal neuromas, pheochromocytoma and medullary carcinoma of the thyroid—a syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Syndrome of bilateral pheochromocytoma, medullary thyroid carcinoma and multiple neuromas. A possible regulatory defect in the differentiation of chromaffin tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Medullary carcinoma of the thyroid gland

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Multiple Endocrine Neoplasia Type IIb: The Most Aggressive Form of Medullary Thyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Multiple endocrine neoplasia type 2. Clinical features and screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Activation of a novel human transforming gene, ret, by DNA rearrangement

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Genetic linkage studies map the multiple endocrine neoplasia type 2 loci to a small interval on chromosome 10q11.2

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Molecular biology of the MEN2 gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Mutation of theRET protooncogene in sporadic medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Germline mutation of RET codon 883 in two cases of de novo MEN 2B.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Ocular manifestations in multiple endocrine neoplasia type 2b

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Alimentary-tract ganglioneuromatosis. A major component of the syndrome of multiple endocrine neoplasia, type 2b

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Association of multiple endocrine neoplasia type 2 and Hirschsprung disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Loss of function effect of RET mutations causing Hirschsprung disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Multiple endocrine neoplasia type 2B (mucosal neuroma syndrome, Wagenmann-Froboese syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Multiple endocrine syndrome type IIb in early childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Multiple endocrine neoplasia type 2: recent progress in diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

The molecular genetics of multiple endocrine neoplasia type 2A and related syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Somatostatin Receptor Scintigraphy for Early Detection of Regional and Distant Metastases of Medullary Carcinoma of the Thyroid

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Results of early thyroidectomy for medullary thyroid carcinoma in children with multiple endocrine neoplasia type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Multiple endocrine neoplasia type 2B: more than an endocrine disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Prophylactic thyroidectomy, based on direct genetic testing, in patients at risk for the multiple endocrine neoplasia type 2 syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Laparoscopic partial adrenalectomy in patients with hereditary forms of pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

Comparison of the hemodynamic parameters of open and laparoscopic adrenalectomy for pheochromocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

The role of intraoperative ultrasonography during laparoscopic adrenalectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2800%2900038-4

7 January 2021

10.1016/S0960-7404(00)00038-4

Identifiers

DOI

1 reference

release_qwfl6qjq3jawrmmsxrpki5jiw4

31 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qwfl6qjq3jawrmmsxrpki5jiw4

24 November 2022

mapped directly with Wikidata item

PubMed ID

11356339

1 reference

PubMed ID

11356339